Citations (163)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Cecilia Trucchi, Chiara Paganino, Daniela Amicizia, Andrea Orsi, Valentino Tisa, Maria Francesca Piazza, Giancarlo Icardi & Filippo Ansaldi. (2019) Universal influenza virus vaccines: what needs to happen next?. Expert Opinion on Biological Therapy 19:7, pages 671-683.
Read now
Read now
F Krammer. (2017) Strategies to induce broadly protective antibody responses to viral glycoproteins. Expert Review of Vaccines 16:5, pages 503-513.
Read now
Read now
Ming Tan & Xi Jiang. (2017) Recent advancements in combination subunit vaccine development. Human Vaccines & Immunotherapeutics 13:1, pages 180-185.
Read now
Read now
Rory D de Vries, Arwen F Altenburg & Guus F Rimmelzwaan. (2015) Universal influenza vaccines, science fiction or soon reality?. Expert Review of Vaccines 14:10, pages 1299-1301.
Read now
Read now
Adam Kenneth Wheatley & Stephen John Kent. (2015) Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. Expert Review of Vaccines 14:9, pages 1227-1239.
Read now
Read now
Yimei Jia, Lakshmi Krishnan & Abdelwahab Omri. (2015) Nasal and pulmonary vaccine delivery using particulate carriers. Expert Opinion on Drug Delivery 12:6, pages 993-1008.
Read now
Read now
Guangyu Zhao, Yu Miao, Yan Guo, Hongjie Qiu, Shihui Sun, Zhihua Kou, Hong Yu, Junfeng Li, Yue Chen, Shibo Jiang, Lanying Du & Yusen Zhou. (2014) Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine. Human Vaccines & Immunotherapeutics 10:12, pages 3649-3658.
Read now
Read now
Cécile van Els, Siri Mjaaland, Lisbeth Næss, Julia Sarkadi, Eva Gonczol, Karen Smith Korsholm, Jon Hansen, Jørgen de Jonge, Gideon Kersten, Jennifer Warner, Amanda Semper, Corine Kruiswijk & Fredrik Oftung. (2014) Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics 10:7, pages 1935-1948.
Read now
Read now
Victor C Huber. (2014) Influenza vaccines: from whole virus preparations to recombinant protein technology. Expert Review of Vaccines 13:1, pages 31-42.
Read now
Read now
Diego Esteban Cargnelutti, María Victoria Sánchez, Nora Marta Mattion & Eduardo Alberto Scodeller. (2013) Development of a universal CTL-based vaccine for influenza. Bioengineered 4:6, pages 374-378.
Read now
Read now
Kenny Roose, Sarah De Baets, Bert Schepens & Xavier Saelens. (2013) Hepatitis B core–based virus–like particles to present heterologous epitopes. Expert Review of Vaccines 12:2, pages 183-198.
Read now
Read now
Michael Schotsaert, Xavier Saelens & Geert Leroux-Roels. (2012) Influenza vaccines: T-cell responses deserve more attention. Expert Review of Vaccines 11:8, pages 949-962.
Read now
Read now
Zichria Zakay-Rones. (2010) Human influenza vaccines and assessment of immunogenicity. Expert Review of Vaccines 9:12, pages 1423-1439.
Read now
Read now
Jürgen Stech. (2010) Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984. Expert Opinion on Therapeutic Patents 20:3, pages 447-450.
Read now
Read now
Selma Calcagnile & Gian Vincenzo Zuccotti. (2010) The virosomal adjuvanted influenza vaccine. Expert Opinion on Biological Therapy 10:2, pages 191-200.
Read now
Read now
Articles from other publishers (148)
Willemijn Frederique Rijnink, Daniel Stadlbauer, Eduard Puente-Massaguer, Nisreen M. A. Okba, Ericka Kirkpatrick Roubidoux, Shirin Strohmeier, Philip A. Mudd, Aaron Schmitz, Ali Ellebedy, Meagan McMahon & Florian Krammer. (2023) Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses. Journal of Virology 97:11.
Crossref
Crossref
Keegan Braz Gomes, Yi-Nan Zhang, Yi-Zong Lee, Mor Eldad, Alexander Lim, Garrett Ward, Sarah Auclair, Linling He & Jiang Zhu. (2023) Single-Component Multilayered Self-Assembling Protein Nanoparticles Displaying Extracellular Domains of Matrix Protein 2 as a Pan-influenza A Vaccine. ACS Nano.
Crossref
Crossref
Anna A. Zykova, Elena A. Blokhina, Liudmila A. Stepanova, Marina A. Shuklina, Olga O. Ozhereleva, Liudmila M. Tsybalova, Victor V. Kuprianov & Nikolai V. Ravin. (2023) Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection. Molecules 28:18, pages 6441.
Crossref
Crossref
Ujjwal Kumar, Priya Goyal, Zaid K. Madni, Kajal Kamble, Vineet Gaur, Maitreyi S. Rajala & Dinakar M. Salunke. (2023) A structure and knowledge-based combinatorial approach to engineering universal scFv antibodies against influenza M2 protein. Journal of Biomedical Science 30:1.
Crossref
Crossref
Di Ma, Shengyuan Tian, Qingqing Qin, Yonghui Yu, Jun Jiao, Xiaolu Xiong, Yan Guo, Xingxiao Zhang & Xuan Ouyang. (2023) Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model. Vaccine 41:30, pages 4402-4413.
Crossref
Crossref
Lili Shi, Ying Long, Yanyan Zhu, Jingjian Dong, Yan Chen, Hao Feng & Xianliang Sun. (2023) VLPs containing stalk domain and ectodomain of matrix protein 2 of influenza induce protection in mice. Virology Journal 20:1.
Crossref
Crossref
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, Abyson Joseph, Ruchir Rastogi, Nupur Mehrotra Arora & Prabuddha K. Kundu. (2023) Platforms, advances, and technical challenges in virus-like particles-based vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Norbert Pardi, Juan Manuel Carreño, George O’Dell, Jessica Tan, Csaba Bajusz, Hiromi Muramatsu, Willemijn Rijnink, Shirin Strohmeier, Madhumathi Loganathan, Dominika Bielak, Molly M. H. Sung, Ying K. Tam, Florian Krammer & Meagan McMahon. (2022) Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses. Nature Communications 13:1.
Crossref
Crossref
Wen-Chien Wang, Ekramy E. Sayedahmed, Suryaprakash Sambhara & Suresh K. Mittal. (2022) Progress towards the Development of a Universal Influenza Vaccine. Viruses 14:8, pages 1684.
Crossref
Crossref
Rudra Prasad Roy & Laxmi Devi. (2022) Strategy construction to minimize the limitation of respiratory viral vaccine development. Indian Journal of Microbiology Research 9:1, pages 1-8.
Crossref
Crossref
Teodora Oltean, Lorena Itati Ibanez, Tatyana Divert, Tine Ysenbaert, Hannelore Van Eeckhoutte, Vera Goossens, Michael Schotsaert, Ken Bracke, Bert Schepens, Jonathan Maelfait, Nozomi Takahashi, Xavier Saelens & Peter Vandenabeele. (2022) Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies. Cell Death & Disease 13:3.
Crossref
Crossref
Anna A. Zykova, Elena A. Blokhina, Liudmila A. Stepanova, Marina A. Shuklina, Liudmila M. Tsybalova, Victor V. Kuprianov & Nikolai V. Ravin. (2022) Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection. Nanomedicine: Nanotechnology, Biology and Medicine 39, pages 102463.
Crossref
Crossref
Minjin Kim, Yucheol Cheong, Jinhee Lee, Jongkwan Lim, Sanguine Byun, Yo Han Jang & Baik Lin Seong. (2021) A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model. Frontiers in Immunology 12.
Crossref
Crossref
Tanja Becker, Husni Elbahesh, Leslie A Reperant, Guus F Rimmelzwaan & Albert D M E Osterhaus. (2021) Influenza Vaccines: Successes and Continuing Challenges. The Journal of Infectious Diseases 224:Supplement_4, pages S405-S419.
Crossref
Crossref
Silvie Van den Hoecke, Marlies Ballegeer, Bram Vrancken, Lei Deng, Emma R. Job, Kenny Roose, Bert Schepens, Lien Van Hoecke, Philippe Lemey & Xavier Saelens. (2021)
In Vivo
Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression
. mBio 12:4.
Crossref
Crossref
Mei Peng Tan, Wen Siang Tan, Noorjahan Banu Mohamed Alitheen & Wei Boon Yap. (2021) M2e-Based Influenza Vaccines with Nucleoprotein: A Review. Vaccines 9:7, pages 739.
Crossref
Crossref
Sukmo Kang, Yujin Kim, Yumi Shin, Ji-Joon Song & Sangyong Jon. (2021) Antigen-Presenting, Self-Assembled Protein Nanobarrels as an Adjuvant-Free Vaccine Platform against Influenza Virus. ACS Nano 15:6, pages 10722-10732.
Crossref
Crossref
Han Zhang, Huaguo Zheng, Peng Guo, Liuyi Hu, Zihao Wang, Jiuru Wang, Ying Ju & Songdong Meng. (2021)
Broadly Protective CD8
+
T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine
. Journal of Virology 95:12.
Crossref
Crossref
Maya Sangesland & Daniel Lingwood. (2021) Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines. Vaccines 9:2, pages 125.
Crossref
Crossref
Semmannan Kalaiyarasu, Sandeep Bhatia, Niranjan Mishra, Dhanapal Senthil Kumar, Manoj Kumar, Richa Sood, Katherukamem Rajukumar, Boopathi Ponnusamy, Dhruv Desai & Vijendra Pal Singh. (2021) Elicitation of Highly Pathogenic Avian Influenza H5N1 M2e and HA2-Specific Humoral and Cell-Mediated Immune Response in Chicken Following Immunization With Recombinant M2e–HA2 Fusion Protein. Frontiers in Veterinary Science 7.
Crossref
Crossref
Lucas J. Kerstetter, Stephen Buckley, Carly M. Bliss & Lynda Coughlan. (2021) Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses. Frontiers in Immunology 11.
Crossref
Crossref
Qiong-Yan Li, Man-Man Xu, Hang Dong, Jin-Hui Zhao, Jun-Hong Xing, Guan Wang, Jia-Yun Yao, Hai-Bin Huang, Chun-Wei Shi, Yan-Long Jiang, Jian-Zhong Wang, Yuan-Huan Kang, Naveed Ullah, Wen-Tao Yang, Gui-Lian Yang & Chun-Feng Wang. (2020) Lactobacillus plantarum surface-displayed influenza antigens (NP-M2) with FliC flagellin stimulate generally protective immune responses against H9N2 influenza subtypes in chickens. Veterinary Microbiology 249, pages 108834.
Crossref
Crossref
Jiangxue Wei, Zhengjun Li, Yanli Yang, Xiaowei Ma, Wenqi An, Guanghui Ma, Zhiguo Su & Songping Zhang. (2020) A biomimetic VLP influenza vaccine with interior NP/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy. Vaccine 38:38, pages 5987-5996.
Crossref
Crossref
M. A Shuklina, L. A Stepanova, A. A. Kovaleva, A. V. Korotkov, A. A. Shaldzhyan, M. V. Zaitceva, E. I. Eletskaya & L. M. Tsybalova. (2020) Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tcell response in mice. Medical Immunology (Russia) 22:2, pages 357-370.
Crossref
Crossref
Rongyuan Gao, Zizhang Sheng, Chithra C. Sreenivasan, Dan Wang & Feng Li. (2020) Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function. Viruses 12:3, pages 276.
Crossref
Crossref
Krystina L. Hess & Christopher M. Jewell. (2019) Phage display as a tool for vaccine and immunotherapy development. Bioengineering & Translational Medicine 5:1.
Crossref
Crossref
Mohamed Elaish, Ming Xia, John M. Ngunjiri, Amir Ghorbani, Hyesun Jang, Mahesh KC, Michael C. Abundo, Santosh Dhakal, Renukaradhya Gourapura, Xi Jiang & Chang-Won Lee. (2019) Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens. Vaccine 37:43, pages 6454-6462.
Crossref
Crossref
Aritraa Lahiri, Shayan Sharif & Amirul Islam Mallick. (2019) Intragastric delivery of recombinant Lactococcus lactis displaying ectodomain of influenza matrix protein 2 (M2e) and neuraminidase (NA) induced focused mucosal and systemic immune responses in chickens. Molecular Immunology 114, pages 497-512.
Crossref
Crossref
Koen Sedeyn & Xavier Saelens. (2019) New antibody-based prevention and treatment options for influenza. Antiviral Research 170, pages 104562.
Crossref
Crossref
Wenling Wang, Baoying Huang, Xiuping Wang, Wenjie Tan & Li Ruan. (2019) Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats. Virologica Sinica 34:5, pages 583-591.
Crossref
Crossref
Weina Sun, Allen Zheng, Robert Miller, Florian Krammer & Peter Palese. (2019) An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains. Vaccines 7:3, pages 117.
Crossref
Crossref
Peiyang Ding, Qianyue Jin, Wen Zhou, Yongxiao Chai, Xiao Liu, Yao Wang, Xinxin Chen, Junqing Guo, Ruiguang Deng, George F. Gao & Gaiping Zhang. (2019) A Universal Influenza Nanovaccine for “Mixing Vessel” Hosts Confers Potential Ability to Block Cross‐Species Transmission. Advanced Healthcare Materials 8:16.
Crossref
Crossref
Leonardo D. Estrada & Stacey Schultz-Cherry. (2019) Development of a Universal Influenza Vaccine. The Journal of Immunology 202:2, pages 392-398.
Crossref
Crossref
Liudmila A. Stepanova, Eugenia S. Mardanova, Marina A. Shuklina, Elena A. Blokhina, Roman Y. Kotlyarov, Marina V. Potapchuk, Anna A. Kovaleva, Inna G. Vidyaeva, Alexandr V. Korotkov, Elizaveta I. Eletskaya, Nikolai V. Ravin & Liudmila M. Tsybalova. (2018) Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes. Journal of Biomedical Science 25:1.
Crossref
Crossref
Seyed Mostafa Jalili Kolour, Farida Behzadian, Behrokh Farahmand & Salimeh Raeisi. (2018) Design of a Universal Influenza A Vaccine Candidate Based on M2e.FliC; Immunoinformatics Analysis, Protein Modeling, and Its Expression in Escherichia coli. Jundishapur Journal of Microbiology In Press:In Press.
Crossref
Crossref
Alan J Hay & John W McCauley. (2018) The WHO global influenza surveillance and response system (GISRS)-A future perspective. Influenza and Other Respiratory Viruses 12:5, pages 551-557.
Crossref
Crossref
Rory de Vries, Sander Herfst & Mathilde Richard. (2018) Avian Influenza A Virus Pandemic Preparedness and Vaccine Development. Vaccines 6:3, pages 46.
Crossref
Crossref
Florian Krammer, Adolfo García-Sastre & Peter Palese. (2018) Is It Possible to Develop a “Universal” Influenza Virus Vaccine?. Cold Spring Harbor Perspectives in Biology 10:7, pages a028845.
Crossref
Crossref
Peter Pushko, Irina Tretyakova, Rachmat Hidajat, Xiangjie Sun, Jessica A. Belser & Terrence M. Tumpey. (2018) Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone. Vaccine 36:29, pages 4346-4353.
Crossref
Crossref
Mehran Dabaghian, Ali Mohammad Latifi, Majid Tebianian, Hamid NajmiNejad & Seyyed Mahmoud Ebrahimi. (2018) Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model. Vaccine 36:20, pages 2886-2895.
Crossref
Crossref
Arun Kumar, Trine Sundebo Meldgaard & Sylvie Bertholet. (2018) Novel Platforms for the Development of a Universal Influenza Vaccine. Frontiers in Immunology 9.
Crossref
Crossref
Hyunsuh KimRobert G. WebsterRichard J. Webby. (2018) Influenza Virus: Dealing with a Drifting and Shifting Pathogen. Viral Immunology 31:2, pages 174-183.
Crossref
Crossref
D G Eliasson, A Omokanye, K Schön, U A Wenzel, V Bernasconi, M Bemark, A Kolpe, K El Bakkouri, T Ysenbaert, L Deng, W Fiers, X Saelens & N Lycke. (2018) M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection. Mucosal Immunology 11:1, pages 273-289.
Crossref
Crossref
Ahmed O. Hassan, Omar Amen, Ekramy E. Sayedahmed, Sai V. Vemula, Samuel Amoah, Ian York, Shivaprakash Gangappa, Suryaprakash Sambhara & Suresh K. Mittal. (2017) Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses. PLOS ONE 12:10, pages e0186244.
Crossref
Crossref
Eun Kim, Gye-Yeong Han & Huan Nguyen. (2017) An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice. Viruses 9:8, pages 234.
Crossref
Crossref
David L. Suarez & Mary J. Pantin-Jackwood. (2017) Recombinant viral-vectored vaccines for the control of avian influenza in poultry. Veterinary Microbiology 206, pages 144-151.
Crossref
Crossref
L. M. Tsybalova, L. A. Stepanova, R. Yu. Kotlyarov, E. A. Blokhina, M. A. Shuklina, E. S. Mardanova, A. V. Korotkov, M. V. Potapchuk & N. V. Ravin. (2017) Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein. Epidemiology and Vaccine Prevention 16:3, pages 65-70.
Crossref
Crossref
Jochen Pendzialek, Kenny Roose, Anouk Smet, Bert Schepens, Peter Kufer, Tobias Raum, Patrick A. Baeuerle, Markus Muenz, Xavier Saelens & Walter Fiers. (2017) Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection. Antiviral Research 141, pages 155-164.
Crossref
Crossref
Silvie Van den Hoecke, Katrin Ehrhardt, Annasaheb Kolpe, Karim El Bakkouri, Lei Deng, Hendrik Grootaert, Steve Schoonooghe, Anouk Smet, Mostafa Bentahir, Kenny Roose, Michael Schotsaert, Bert Schepens, Nico Callewaert, Falk Nimmerjahn, Peter Staeheli, Hartmut Hengel & Xavier Saelens. (2017) Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies. Journal of Virology 91:7.
Crossref
Crossref
R. Nachbagauer & F. Krammer. (2017) Universal influenza virus vaccines and therapeutic antibodies. Clinical Microbiology and Infection 23:4, pages 222-228.
Crossref
Crossref
Lulan Wang, Su-Yang Liu, Hsiang-Wen Chen, Juan Xu, Maxime Chapon, Tao Zhang, Fan Zhou, Yao E. Wang, Natalie Quanquin, Guiqin Wang, Xiaoli Tian, Zhanlong He, Longding Liu, Wenhai Yu, David Jesse Sanchez, Yuying Liang, Taijiao Jiang, Robert Modlin, Barry R. Bloom, Qihan Li, Jane C. Deng, Paul Zhou, F. Xiao-Feng Qin & Genhong Cheng. (2017) Generation of a Live Attenuated Influenza Vaccine that Elicits Broad Protection in Mice and Ferrets. Cell Host & Microbe 21:3, pages 334-343.
Crossref
Crossref
R.D. de Vries, A.F. Altenburg & G.F. Rimmelzwaan. (2016) Universal influenza vaccines: a realistic option?. Clinical Microbiology and Infection 22, pages S120-S124.
Crossref
Crossref
I. B. Esmagambetov, S. V. Alekseeva, K. S. Sayadyan & M. M. Shmarov. (2016) CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS. Russian Journal of Infection and Immunity 6:2, pages 117-132.
Crossref
Crossref
Ali AmeghiYones Pilehvar-SoltanahmadiBehzad BaradaranAbolfazl BarzegarMorteza TaghizadehNosratollah ZarghamiKhosrow Aghaiypour. (2016) Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice. Viral Immunology 29:4, pages 228-234.
Crossref
Crossref
Michael Schotsaert, Tine Ysenbaert, Anouk Smet, Bert Schepens, Dieter Vanderschaeghe, Svetlana Stegalkina, Thorsten U. Vogel, Nico Callewaert, Walter Fiers & Xavier Saelens. (2016) Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies. Scientific Reports 6:1.
Crossref
Crossref
Darrell R. Kapczynski, Terrence M. Tumpey, Rachmat Hidajat, Aniko Zsak, Klaudia Chrzastek, Irina Tretyakova & Peter Pushko. (2016) Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses. Vaccine 34:13, pages 1575-1581.
Crossref
Crossref
Xupeng Mu, Kebang Hu, Mohan Shen, Ning Kong, Changhao Fu, Weiqun Yan & Anhui Wei. (2016) Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA). Journal of Virological Methods 228, pages 84-90.
Crossref
Crossref
Weiguang Zeng, Kylie J. Horrocks, Amabel C. L. Tan & David C. Jackson. (2016) Chemical Synthesis of Monomeric, Dimeric and Tetrameric Forms of the Ectodomain of Influenza Matrix 2 Protein. European Journal of Organic Chemistry 2016:5, pages 1054-1059.
Crossref
Crossref
Irina Tretyakova, Rachmat Hidajat, Garrett Hamilton, Noah Horn, Brian Nickols, Raphael O. Prather, Terrence M. Tumpey & Peter Pushko. (2016) Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein. Virology 487, pages 163-171.
Crossref
Crossref
Jie Zhang, Hui-Ying Fan, Zhen Zhang, Juan Zhang, Jiao Zhang, Jian-Ni Huang, Yu Ye & Ming Liao. (2016) Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice. Vaccine 34:5, pages 622-629.
Crossref
Crossref
Ali Ameghi, Behzad Baradaran, Khosrow Aghaiypour, Abolfazl Barzegar, Yones Pilehvar-Soltanahmadi, Masood Moghadampour, Morteza Taghizadeh & Nosratollah Zarghami. (2015) Generation of New M2e-HA2 Fusion Chimeric Peptide to Development of a Recombinant Fusion Protein Vaccine. Advanced Pharmaceutical Bulletin 5:Suppl 1, pages 673-681.
Crossref
Crossref
Masanori Terajima, Mary Dawn T. Co, John Cruz & Francis A. Ennis. (2015) High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children. Journal of Infectious Diseases 212:7, pages 1052-1060.
Crossref
Crossref
Peter C. Soema, Ronald Kompier, Jean-Pierre Amorij & Gideon F.A. Kersten. (2015) Current and next generation influenza vaccines: Formulation and production strategies. European Journal of Pharmaceutics and Biopharmaceutics 94, pages 251-263.
Crossref
Crossref
Weiguang Zeng, Amabel C.L. Tan, Kylie Horrocks & David C. Jackson. (2015) A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. Vaccine 33:30, pages 3526-3532.
Crossref
Crossref
Min-Chul Kim, Jeong Woo Lee, Hyo-Jick Choi, Yu-Na Lee, Hye Suk Hwang, Jongsang Lee, Cheol Kim, Jong Seok Lee, Carlo Montemagno, Mark R. Prausnitz & Sang-Moo Kang. (2015) Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection. Journal of Controlled Release 210, pages 208-216.
Crossref
Crossref
Florian Krammer. (2015) Emerging influenza viruses and the prospect of a universal influenza virus vaccine. Biotechnology Journal 10:5, pages 690-701.
Crossref
Crossref
Ki Joon Cho, Bert Schepens, Jong Hyeon Seok, Sella Kim, Kenny Roose, Ji-Hye Lee, Rodrigo Gallardo, Evelien Van Hamme, Joost Schymkowitz, Frederic Rousseau, Walter Fiers, Xavier Saelens & Kyung Hyun Kim. (2015) Structure of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus in Complex with a Protective Monoclonal Antibody. Journal of Virology 89:7, pages 3700-3711.
Crossref
Crossref
Alicia M. Fry, Weimin Zhong & Larisa V. Gubareva. (2015) Advancing Treatment Options for Influenza: Challenges With the Human Influenza Challenge. Journal of Infectious Diseases 211:7, pages 1033-1035.
Crossref
Crossref
Eleanor L. Ramos, Jennifer L. Mitcham, Teri D. Koller, Aurelio Bonavia, Dale W. Usner, Ganesh Balaratnam, Paul Fredlund & Kristine M. Swiderek. (2015) Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza. Journal of Infectious Diseases 211:7, pages 1038-1044.
Crossref
Crossref
Florian Krammer & Peter Palese. (2015) Advances in the development of influenza virus vaccines. Nature Reviews Drug Discovery 14:3, pages 167-182.
Crossref
Crossref
Naru Zhang, Bo-Jian Zheng, Lu Lu, Yusen Zhou, Shibo Jiang & Lanying Du. (2015) Advancements in the development of subunit influenza vaccines. Microbes and Infection 17:2, pages 123-134.
Crossref
Crossref
Arwen Altenburg, Joost Kreijtz, Rory de Vries, Fei Song, Robert Fux, Guus Rimmelzwaan, Gerd Sutter & Asisa Volz. (2014) Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases. Viruses 6:7, pages 2735-2761.
Crossref
Crossref
Graeme E. Price, Chia-Yun Lo, Julia A. Misplon & Suzanne L. Epstein. (2014) Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model. Journal of Virology 88:11, pages 6019-6030.
Crossref
Crossref
Ming Tan & Xi Jiang. (2014) Subviral particle as vaccine and vaccine platform. Current Opinion in Virology 6, pages 24-33.
Crossref
Crossref
Han Zhang, Li Wang, Richard Compans & Bao-Zhong Wang. (2014) Universal Influenza Vaccines, a Dream to Be Realized Soon. Viruses 6:5, pages 1974-1991.
Crossref
Crossref
I. B. Esmagambetov, E. S. Sedova, D. N. Shcherbinin, A. A. Lysenko, M. N. Garas, M. M. Shmarov & D. Yu. Logunov. (2014) Construction of recombinant adenoviral vector expressing genes of the conservative proteins M2 “ion channel” and nucleoprotein of influenza A virus. Molecular Genetics, Microbiology and Virology 29:2, pages 69-76.
Crossref
Crossref
M. Zheng, J. Luo & Z. Chen. (2013) Development of universal influenza vaccines based on influenza virus M and NP genes. Infection 42:2, pages 251-262.
Crossref
Crossref
Andreas Handel, Victoria Akin, Sergei S. Pilyugin, Veronika Zarnitsyna & Rustom Antia. (2014) How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example. Journal of The Royal Society Interface 11:92, pages 20131083.
Crossref
Crossref
Bao-Zhong Wang, Harvinder S. Gill, Cheng He, Changbo Ou, Li Wang, Ying-Chun Wang, Hao Feng, Han Zhang, Mark R. Prausnitz & Richard W. Compans. (2014) Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity. Journal of Controlled Release 178, pages 1-7.
Crossref
Crossref
Annett Hessel, Helga Savidis-Dacho, Sogue Coulibaly, Daniel Portsmouth, Thomas R. Kreil, Brian A. Crowe, Michael G. Schwendinger, Andreas Pilz, P. Noel Barrett, Falko G. Falkner & Birgit Schäfer. (2014) MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses. PLoS ONE 9:2, pages e88340.
Crossref
Crossref
Nima Mirzaei, Rakhshandeh Nategh, Hoorieh Soleimanjahi, Nour Amirmozafari, Farhad Rezaei & Talat Mokhtari Azad. (2014) Construction of Recombinant Bacmid Containing M2e-Ctxb and Producing the Fusion Protein in Insect Cell Lines. Iranian Red Crescent Medical Journal 16:2.
Crossref
Crossref
Li Wang, Annie Hess, Timothy Z. Chang, Ying-Chun Wang, Julie A. Champion, Richard W. Compans & Bao-Zhong Wang. (2014) Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines. Nanomedicine: Nanotechnology, Biology and Medicine 10:2, pages 473-482.
Crossref
Crossref
Ying Yin, Sheng Zhang, Chenguang Cai, Jun Zhang, Dayong Dong, Qiang Guo, Ling Fu, Junjie Xu & Wei Chen. (2014) Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine. Immunobiology 219:2, pages 97-103.
Crossref
Crossref
Eun-Ha Kim, Jun-Han Lee, Philippe Noriel Q Pascua, Min-Suk Song, Yun-Hee Baek, Hyeok-il Kwon, Su-Jin Park, Gyo-Jin Lim, Arun Decano, Mohammed YE Chowdhury, Su-Kyung Seo, Man Ki Song, Chul-Joong Kim & Young-Ki Choi. (2013) Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice. Virology Journal 10:1.
Crossref
Crossref
I. V. Tarasenko, A. I. Taranov, A. P. Firsov & S. V. Dolgov. (2013) Expression of the nucleotide sequence for the M2e peptide of avian influenza virus in transgenic tobacco plants. Applied Biochemistry and Microbiology 49:8, pages 695-701.
Crossref
Crossref
Mariana Baz, Catherine J. Luke, Xing Cheng, Hong Jin & Kanta Subbarao. (2013) H5N1 vaccines in humans. Virus Research 178:1, pages 78-98.
Crossref
Crossref
Nani Wibowo, Yap P. Chuan, Linda H.L. Lua & Anton P.J. Middelberg. (2013) Modular engineering of a microbially-produced viral capsomere vaccine for influenza. Chemical Engineering Science 103, pages 12-20.
Crossref
Crossref
Irina Tretyakova, Melissa B. Pearce, Ruth Florese, Terrence M. Tumpey & Peter Pushko. (2013) Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses. Virology 442:1, pages 67-73.
Crossref
Crossref
Megan K. L. MacLeod, Alexandria David, Niyun Jin, Laura Noges, Jieru Wang, John W. Kappler & Philippa Marrack. (2013) Influenza Nucleoprotein Delivered with Aluminium Salts Protects Mice from an Influenza A Virus That Expresses an Altered Nucleoprotein Sequence. PLoS ONE 8:4, pages e61775.
Crossref
Crossref
Jason M. Weaver, Hongmei Yang, David Roumanes, F. Eun-Hyung Lee, Hulin Wu, John J. Treanor & Tim R. Mosmann. (2013) Increase in IFNγ−IL-2+ Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza. PLoS ONE 8:3, pages e57275.
Crossref
Crossref
Hana Kammoun, Xavier Roux, Dominique Raze, Anne-Sophie Debrie, Marina De Filette, Tine Ysenbaert, Nathalie Mielcarek, Xavier Saelens, Walter Fiers & Camille Locht. (2013) Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e. PLoS ONE 8:3, pages e59198.
Crossref
Crossref
Lorena Itatí Ibañez, Kenny Roose, Marina De Filette, Michael Schotsaert, Jessica De Sloovere, Stefan Roels, Charlotte Pollard, Bert Schepens, Johan Grooten, Walter Fiers & Xavier Saelens. (2013) M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A. PLoS ONE 8:3, pages e59081.
Crossref
Crossref
Brian J. Laidlaw, Vilma Decman, Mohammed-Alkhatim A. Ali, Michael C. Abt, Amaya I. Wolf, Laurel A. Monticelli, Krystyna Mozdzanowska, Jill M. Angelosanto, David Artis, Jan Erikson & E. John Wherry. (2013) Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity. PLoS Pathogens 9:3, pages e1003207.
Crossref
Crossref
M Schotsaert, T Ysenbaert, K Neyt, L I Ibañez, P Bogaert, B Schepens, B N Lambrecht, W Fiers & X Saelens. (2013) Natural and long-lasting cellular immune responses against influenza in the M2e-immune host. Mucosal Immunology 6:2, pages 276-287.
Crossref
Crossref
Li Wang, Ying-Chun Wang, Hao Feng, Tamanna Ahmed, Richard W. Compans & Bao-Zhong Wang. (2013) Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice. BioMed Research International 2013, pages 1-12.
Crossref
Crossref
Kaleb A. Reese, Christopher Lupfer, Rudd C. Johnson, Georgi M. Mitev, Valerie M. Mullen, Bruce L. Geller & Manoj Pastey. (2013) A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens. Veterinary Medicine International 2013, pages 1-8.
Crossref
Crossref
Elena A. Blokhina, Victor V. Kuprianov, Ludmila A. Stepanova, Ludmila M. Tsybalova, Oleg I. Kiselev, Nikolai V. Ravin & Konstantin G. Skryabin. (2013) A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles. Virology 435:2, pages 293-300.
Crossref
Crossref
Xiaoyu Liu, Jianqiang Guo, Su Han, Lihong Yao, Aijun Chen, Qi Yang, Hong Bo, Pengwei Xu, Jiyong Yin & Zhiqing Zhang. (2012) Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin. Vaccine 30:46, pages 6527-6533.
Crossref
Crossref
Carolien E. van de Sandt, Joost H. C. M. Kreijtz & Guus F. Rimmelzwaan. (2012) Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses. Viruses 4:9, pages 1438-1476.
Crossref
Crossref
Bao-Zhong Wang, Harvinder S. Gill, Sang-Moo Kang, Li Wang, Ying-Chun Wang, Elena V. Vassilieva & Richard W. Compans. (2012) Enhanced Influenza Virus-Like Particle Vaccines Containing the Extracellular Domain of Matrix Protein 2 and a Toll-Like Receptor Ligand. Clinical and Vaccine Immunology 19:8, pages 1119-1125.
Crossref
Crossref
Mohammad Hossein Zabeh Jazi, Mehran Dabaghian, Majid Tebianian, Mohammad Javad Gharagozlou & Seyyed Mahmoud Ebrahimi. (2012) In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine. Virus Research 167:2, pages 219-225.
Crossref
Crossref
Christine M Oshansky & Paul G Thomas. (2012) The human side of influenza. Journal of Leukocyte Biology 92:1, pages 83-96.
Crossref
Crossref
Ma-ping Deng, Zhi-hong Hu, Hua-lin Wang & Fei Deng. (2012) Developments of subunit and VLP vaccines against influenza a virus. Virologica Sinica 27:3, pages 145-153.
Crossref
Crossref
Bruce Y. Lee, Julie H. Y. Tai, Sarah M. McGlone, Rachel R. Bailey, Angela R. Wateska, Shanta M. Zimmer, Richard K. Zimmerman & Michael M. Wagner. (2011) The potential economic value of a ‘universal’ (multi‐year) influenza vaccine. Influenza and Other Respiratory Viruses 6:3, pages 167-175.
Crossref
Crossref
Bruno G. De Geest, Monique A. Willart, Hamida Hammad, Bart N. Lambrecht, Charlotte Pollard, Pieter Bogaert, Marina De Filette, Xavier Saelens, Chris Vervaet, Jean Paul Remon, Johan Grooten & Stefaan De Koker. (2012) Polymeric Multilayer Capsule-Mediated Vaccination Induces Protective Immunity Against Cancer and Viral Infection. ACS Nano 6:3, pages 2136-2149.
Crossref
Crossref
Huixun Shao. (2012) The evolution of influenza viruses. Health 04:10, pages 1000-1005.
Crossref
Crossref
Maryam Esghaei, Seyed Hamid Reza Monavari, Masoumeh Tavassoti-Kheiri, Mahmoud Shamsi-Shahrabadi, Behnaz Heydarchi, Behrokh Farahmand, Maryam Saleh & Fatemeh Fotouhi. (2012) Expression of the influenza M2 protein in three different eukaryotic cell lines. Journal of Virological Methods 179:1, pages 161-165.
Crossref
Crossref
Kenny Roose, Michael Schotsaert, Karim El Bakkouri, Bert Schepens, Walter Fiers & Xavier Saelens. 2012. Development of Novel Vaccines. Development of Novel Vaccines
205
232
.
Birgit Weinberger & Beatrix Grubeck-Loebenstein. 2012. Immunosenescence. Immunosenescence
157
174
.
Yanwei Zhong, Jiong Cai, Chuanfu Zhang, Xiaoyan Xing, Enqiang Qin, Jing He, Panyong Mao, Jun Cheng, Kun Liu, Dongping Xu & Hongbin Song. (2011) Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A. Virology Journal 8:1.
Crossref
Crossref
J.H.C.M. Kreijtz, R.A.M. Fouchier & G.F. Rimmelzwaan. (2011) Immune responses to influenza virus infection. Virus Research 162:1-2, pages 19-30.
Crossref
Crossref
Byoung-Shik Shim, Young Ki Choi, Cheol-Heui Yun, Eu-Gene Lee, Yoon Seong Jeon, Sung-Moo Park, In Su Cheon, Dong-Hyun Joo, Chung Hwan Cho, Min-Suk Song, Sang-Uk Seo, Young-Ho Byun, Hae-Jung Park, Haryoung Poo, Baik Lin Seong, Jae Ouk Kim, Huan Huu Nguyen, Konrad Stadler, Dong Wook Kim, Kee-Jong Hong, Cecil Czerkinsky & Man Ki Song. (2011) Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza. PLoS ONE 6:11, pages e27953.
Crossref
Crossref
M. Anthony Moody, Ruijun Zhang, Emmanuel B. Walter, Christopher W. Woods, Geoffrey S. Ginsburg, Micah T. McClain, Thomas N. Denny, Xi Chen, Supriya Munshaw, Dawn J. Marshall, John F. Whitesides, Mark S. Drinker, Joshua D. Amos, Thaddeus C. Gurley, Joshua A. Eudailey, Andrew Foulger, Katherine R. DeRosa, Robert Parks, R. Ryan Meyerhoff, Jae-Sung Yu, Daniel M. Kozink, Brice E. Barefoot, Elizabeth A. Ramsburg, Surender Khurana, Hana Golding, Nathan A. Vandergrift, S. Munir Alam, Georgia D. Tomaras, Thomas B. Kepler, Garnett Kelsoe, Hua-Xin Liao & Barton F. Haynes. (2011) H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination. PLoS ONE 6:10, pages e25797.
Crossref
Crossref
Ab Osterhaus, Ron Fouchier & Guus Rimmelzwaan. (2011) Towards universal influenza vaccines?. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1579, pages 2766-2773.
Crossref
Crossref
Pieter LA Fraaij, Rogier Bodewes, Albert DME Osterhaus & Guus F Rimmelzwaan. (2011) The ins and outs of universal childhood influenza vaccination. Future Microbiology 6:10, pages 1171-1184.
Crossref
Crossref
Kai Li, Jing Luo, Chengmin Wang & Hongxuan He. (2011) α-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice. Vaccine 29:44, pages 7711-7717.
Crossref
Crossref
Anton P.J. Middelberg, Tania Rivera-Hernandez, Nani Wibowo, Linda H.L. Lua, Yuanyuan Fan, Graham Magor, Cindy Chang, Yap P. Chuan, Michael F. Good & Michael R. Batzloff. (2011) A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine 29:41, pages 7154-7162.
Crossref
Crossref
Peter Pushko, Melissa B. Pearce, Attiya Ahmad, Irina Tretyakova, Gale Smith, Jessica A. Belser & Terrence M. Tumpey. (2011) Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Vaccine 29:35, pages 5911-5918.
Crossref
Crossref
Ying Yin, Hao Li, Shipo Wu, Dayong Dong, Jun Zhang, Ling Fu, Junjie Xu & Wei Chen. (2011) Hepatitis B virus core particles displaying Mycobacterium tuberculosis antigen ESAT-6 enhance ESAT-6-specific immune responses. Vaccine 29:34, pages 5645-5651.
Crossref
Crossref
Ki Seok Park, Yong Bok Seo, Ji Yeung Lee, Se Jin Im, Sang Hwan Seo, Min Suk Song, Young Ki Choi & Young Chul Sung. (2011) Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Vaccine 29:33, pages 5481-5487.
Crossref
Crossref
Weimin Zhong, Ju He, Xiaoling Tang, Feng Liu, Xiuhua Lu, Hui Zeng, Abbas Vafai, Tong-Ming Fu, Jacqueline M. Katz & Kathy Hancock. (2011) Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses. Journal of Immunological Methods 369:1-2, pages 115-124.
Crossref
Crossref
Dubravka Grdic Eliasson, Anja Helgeby, Karin Schön, Caroline Nygren, Karim El-Bakkouri, Walter Fiers, Xavier Saelens, Karin Bengtsson Lövgren, Ida Nyström & Nils Y. Lycke. (2011) A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus. Vaccine 29:23, pages 3951-3961.
Crossref
Crossref
Sophie A. Valkenburg, John A. Rutigliano, Ali H. Ellebedy, Peter C. Doherty, Paul G. Thomas & Katherine Kedzierska. (2011) Immunity to seasonal and pandemic influenza A viruses. Microbes and Infection 13:5, pages 489-501.
Crossref
Crossref
Paul Shapshak, Francesco Chiappelli, Charurut Somboonwit & John Sinnott. (2012) The Influenza Pandemic of 2009. Molecular Diagnosis & Therapy 15:2, pages 63-81.
Crossref
Crossref
R. Bodewes, J. H. C. M. Kreijtz, M. M. Geelhoed-Mieras, G. van Amerongen, R. J. Verburgh, S. E. van Trierum, T. Kuiken, R. A. M. Fouchier, A. D. M. E. Osterhaus & G. F. Rimmelzwaan. (2011) Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets. Journal of Virology 85:6, pages 2695-2702.
Crossref
Crossref
Seyyed Mahmoud Ebrahimi & Majid Tebianian. (2010) Influenza A viruses: why focusing on M2e-based universal vaccines. Virus Genes 42:1, pages 1-8.
Crossref
Crossref
Jae-Min Song, Bao-Zhong Wang, Kyoung-Mi Park, Nico Van Rooijen, Fu-Shi Quan, Min-Chul Kim, Hyun-Tak Jin, Andrew Pekosz, Richard W. Compans & Sang-Moo Kang. (2011) Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity. PLoS ONE 6:1, pages e14538.
Crossref
Crossref
Mariette F. DucatezJustin Bahl, Yolanda GriffinEvelyn Stigger-RosserJohn FranksSubrata BarmanDhanasekaran Vijaykrishna, Ashley WebbYi Guan, Robert G. WebsterGavin J. D. Smith & Richard J. Webby. (2010) Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development. Proceedings of the National Academy of Sciences 108:1, pages 349-354.
Crossref
Crossref
Guangyu Zhao, Shihui Sun, Lanying Du, Wenjun Xiao, Zhitao Ru, Zhihua Kou, Yan Guo, Hong Yu, Shibo Jiang, Yuchun Lone, Bo-Jian Zheng & Yusen Zhou. (2010) An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virology Journal 7:1.
Crossref
Crossref
Dongming Zhou, Te-Lang Wu, Marcio O Lasaro, Brian P Latimer, Elizabeth M Parzych, Ang Bian, Yan Li, Hua Li, Jan Erikson, Zhiquan Xiang & Hildegund CJ Ertl. (2010) A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge. Molecular Therapy 18:12, pages 2182-2188.
Crossref
Crossref
Linda C. Lambert & Anthony S. Fauci. (2010) Influenza Vaccines for the Future. New England Journal of Medicine 363:21, pages 2036-2044.
Crossref
Crossref
Guangyu Zhao, Lanying Du, Wenjun Xiao, Shihui Sun, Yongping Lin, Min Chen, Zhihua Kou, Yuxian He, Sara Lustigman, Shibo Jiang, Bo-Jian Zheng & Yusen Zhou. (2010) Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant. Vaccine 28:44, pages 7233-7240.
Crossref
Crossref
Julia A. Misplon, Chia-Yun Lo, Jon D. Gabbard, S. Mark Tompkins & Suzanne L. Epstein. (2010) Genetic control of immune responses to influenza A matrix 2 protein (M2). Vaccine 28:36, pages 5817-5827.
Crossref
Crossref
David Pejoski, Weiguang Zeng, Steven Rockman, Lorena E Brown & David C Jackson. (2010) A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Immunology & Cell Biology 88:5, pages 605-611.
Crossref
Crossref
Iain Stephenson, Frederick Hayden, Albert Osterhaus, Wendy Howard, Yuri Pervikov, Laszlo Palkonyay & Marie-Paule Kieny. (2010) Report of the fourth meeting on ‘Influenza vaccines that induce broad spectrum and long-lasting immune responses’, World Health Organization and Wellcome Trust, London, United Kingdom, 9–10 November 2009. Vaccine 28:23, pages 3875-3882.
Crossref
Crossref
Lanying Du, Yusen Zhou & Shibo Jiang. (2010) Research and development of universal influenza vaccines. Microbes and Infection 12:4, pages 280-286.
Crossref
Crossref
Sylvie Marché, Bénédicte Lambrecht & Thierry van den Berg. (2010) Evaluation of Different Serologic Markers for the Early Detection of Avian Influenza Infection in Chickens. Avian Diseases 54:s1, pages 690-698.
Crossref
Crossref
Nienke E. van Houten, Kevin A. Henry, George P. Smith & Jamie K. Scott. (2010) Engineering filamentous phage carriers to improve focusing of antibody responses against peptides. Vaccine 28:10, pages 2174-2185.
Crossref
Crossref
Rogier Bodewes, Albert Osterhaus & Guus Rimmelzwaan. (2010) Targets for the Induction of Protective Immunity Against Influenza A Viruses. Viruses 2:1, pages 166-188.
Crossref
Crossref
Alexander A. Rumyantsev, Zhen-xi Zhang, Qing-sheng Gao, Nicolas Moretti, Nathan Brown, Harold Kleanthous, Simon Delagrave, Farshad Guirakhoo, Marc S. Collett & Konstantin V. Pugachev. (2010) Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus. Virology 396:2, pages 329-338.
Crossref
Crossref
Stacey Schultz-Cherry & Jeremy C. Jones. 2010.
63
84
.
Rogier Bodewes, Joost HCM Kreijtz & Guus F Rimmelzwaan. (2009) Yearly influenza vaccinations: a double-edged sword?. The Lancet Infectious Diseases 9:12, pages 784-788.
Crossref
Crossref
Shao-Min Yan & Guang Wu. (2009) Trends in global warming and evolution of matrix protein 2 family from influenza A virus. Interdisciplinary Sciences: Computational Life Sciences 1:4, pages 272-279.
Crossref
Crossref
Shaobo Pei, Ning Xiong, Yong Zhang & Shiyun Chen. (2009) Increasing M2 epitope density enhances systemic and mucosal immune responses to influenza A virus. Biotechnology Letters 31:12, pages 1851-1856.
Crossref
Crossref
A.H. Ellebedy & R.J. Webby. (2009) Influenza vaccines. Vaccine 27, pages D65-D68.
Crossref
Crossref
J. S. Malik Peiris, Wen‐wei Tu & Hui‐ling Yen. (2009)
A novel H1N1 virus causes the first pandemic of the 21
st
century
. European Journal of Immunology 39:11, pages 2946-2954.
Crossref
Crossref
Gabriele Neumann, Takeshi Noda & Yoshihiro Kawaoka. (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:7249, pages 931-939.
Crossref
Crossref
Shao-Min Yan, Zhen-Chong Li & Guang Wu. (2009) Fitting evolutionary process of matrix protein 2 family from influenza A virus using analytical solution of differential equation. Journal of Biomedical Science and Engineering 02:08, pages 587-593.
Crossref
Crossref